Skip to search formSkip to main contentSkip to account menu
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue.
View on Elsevier
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison…
View on Elsevier
Serotonin receptors : their key role in drugs to treat schizophrenia
View on Elsevier
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
TLDR
Atypical antipsychotic drugs as a group appear to be superior to typical neuroleptics with regard to cognitive function, however, available data suggest that these drugs produce significant differences in specific cognitive functions.
View on PubMed
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
The pKi values of 13 reference typical and 7 reference atypical antipsychotic drugs (APDs) for rat striatal dopamine D-1 and D-2 receptor binding sites and cortical serotonin (5-HT2) receptor binding…
View on PubMed
The Role of Serotonin in Antipsychotic Drug Action
  • H. Meltzer
  • Psychology, Medicine
    Neuropsychopharmacology
  • 1 August 1999
View on Nature
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
TLDR
For patients with schizophrenia who prospectively failed to improve with an atypical antipsychotic, clozapine was more effective than switching to another newer atypicals antipsychotics.
View on PubMed
5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release
TLDR
The results suggest that the atypical APDs via 5‐HT2A and D2 receptor blockade, regardless of intrinsic 5-HT1A affinity, may promote the ability of 5- HT1A receptor stimulation to increase mPFC DA release, and provide additional evidence that coadministration of 5‐ HT2A antagonists and typical APDs, which are D2 antagonists, may facilitate 5‐ht1A agonist activity.
View on Wiley
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
TLDR
The authors examined the affinities of 36 typical and atypical antipsychotic agents for the cloned rat 5-hydroxytryptamine-6 and rat5-HT7 receptors in transiently expressed COS-7 cells or stably transfected HEK-293 cells to identify those with high affinity for the newly discovered 5-HT6 receptor.
View on PubMed
Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients
View on Elsevier
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License